Page last updated: 2024-11-05

zonisamide and Epileptic Syndromes

zonisamide has been researched along with Epileptic Syndromes in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Epileptic Syndromes: EPILEPTIC SEIZURES that are of similar type and age of onset and have other similar features (e.g., clinical course, EEG findings, genetic association and neuropathology).

Research Excerpts

ExcerptRelevanceReference
"In five cases, tonic seizures preceded spasms at a median age of 6 weeks."1.51New insights in phenomenology and treatment of epilepsy in CDKL5 encephalopathy. ( Bienvenu, T; Chikvinidze, G; Dulac, O; Epitashvili, N; Gataullina, S; Melikishvili, G; Tabatadze, N, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melikishvili, G1
Epitashvili, N1
Tabatadze, N1
Chikvinidze, G1
Dulac, O1
Bienvenu, T1
Gataullina, S1

Other Studies

1 other study available for zonisamide and Epileptic Syndromes

ArticleYear
New insights in phenomenology and treatment of epilepsy in CDKL5 encephalopathy.
    Epilepsy & behavior : E&B, 2019, Volume: 94

    Topics: Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Electroencephalography; Electro

2019